PGR and cancer: These findings highlight the importance of stromal ERβ and PR in stroma-tumor epithelium crosstalk in modulating cancer progression, but tissue-specific inhibition or activation of these NRs in CAFs is imperative to outline the feasibility of exploiting them as therapeutic cancer targets.